A nationwide team led by researchers at Baylor College of Medicine, Texas Children’s Hospital and UPMC Children’s Hospital of Pittsburgh has proposed a major revision to how Langerhans cell histiocytosis (LCH) is diagnosed and treated after analyzing patients with LCH for several years.
An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%.
Psychedelic-assisted therapy is one step closer to becoming legally available in Colorado, with the state’s first healing center obtaining a license to offer the service this week.
It can happen in an instant—a mother experiences a medical emergency during delivery that requires intensive care.
Liver transplants are becoming a new treatment option for certain colorectal cancer patients whose cancer has spread to their liver and are ineligible for other surgical options. This innovative approach is providing hope to colorectal cancer patients who are otherwise often faced with a grim prognosis.
Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.
Estela Jacinto, a professor of biochemistry and molecular biology at Rutgers Robert Wood Johnson Medical School, has been studying a crucial pathway for human cell growth and metabolism for more than two decades.
The inability to pay for health care in the U.S. has reached a new high, with more than one-third of Americans (35%), or an estimated 91 million people, reporting that they could not access quality health care if they needed it today, according to the latest West Health-Gallup Health care Affordability Index. The Index has been tracking health care affordability and access in the U.S. since 2021.
The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women, the agency announced Friday.
The next two weeks will determine whether a single measles case in Colorado fizzles out or starts an outbreak.